Litigation Details for IPA Technologies Inc. v. Amazon.com, Inc. (D. Del. 2016)
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
IPA Technologies Inc. v. Amazon.com, Inc. (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-12-19 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,010,517; 10,016,415; 10,029,080; 10,030,051; 10,030,059; 10,031,080; 10,031,118; 10,066,003; 10,066,019; 10,080,841; 10,115,021; 10,118,080; 7,967,011; 7,977,080; 8,013,128; 8,022,036; 8,044,046; 8,051,851; 8,069,851; 9,005,056; 9,005,158; 9,020,056; 9,056,051; 9,056,052; 9,056,057; 9,056,059; 9,057,061; 9,061,003; 9,061,005; 9,061,029; 9,061,044; 9,062,158; 9,415,004; 9,415,007; 9,415,008; 9,415,009; 9,415,029; 9,415,043; 9,505,841; 9,841,001; 9,977,036 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in IPA Technologies Inc. v. Amazon.com, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Biologic Drugs cited in IPA Technologies Inc. v. Amazon.com, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for IPA Technologies Inc. v. Amazon.com, Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-05-21 | 126 | Opinion - Memorandum Opinion | embodiments. (See id. at 30; ’115 patent, col. 10:41-42, 10:51-53). Therefore, I construe “Inter-agent… and task coordination language.” (’115 patent, col. 10:49-51). Plaintiff agrees to this. (D.I. 118…thought of as goals to be satisfied.” (’115 patent, col. 10:66-11:1). Thinking “preferably” of an “event…facilitator.” (D.I. 118 at 56) (citing to ’115 patent, col. 10:62-11:7, 12:44-46). Plaintiff does not seem…terms in U.S. Patent Nos. 6,851,115 (“the ’115 patent”), 7,069,560 (“the ’560 patent), and 7,036,128 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
